• Citer

Use of an RNA interference screen-derived mitotic and ceramide pathway metagene to predict response to paclitaxel combination chemotherapy in primary breast cancer

par Swanton, Charles;Juul, Nicolai;Larkin, JM;Eklund, Aron C;Li, Q;Desmedt, Christine ;Sotiriou, Christos ;Pusztai, Lajos;Szallasi, Zoltan
Référence ASCO Annual Meeting(June 4-8, 2010: Chicago, Il, USA), Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings, Vol. Vol 28 (15s)
Publication Publié, 2010

Abstract de conférence

• Détails
• Contenu

Titre:	Use of an RNA interference screen-derived mitotic and ceramide pathway metagene to predict response to paclitaxel combination chemotherapy in primary breast cancer
Auteur:	Swanton, Charles; Juul, Nicolai; Larkin, JM; Eklund, Aron C; Li, Q; Desmedt, Christine; Sotiriou, Christos; Pusztai, Lajos; Szallasi, Zoltan
Informations sur la publication:	ASCO Annual Meeting(June 4-8, 2010: Chicago, Il, USA), Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings, Vol. Vol 28 (15s)
Statut de publication:	Publié, 2010
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais